Secor Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Secor Capital Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-72,621	Closed	-$2.41M	–	558
2016 Q2	$2.41M	Buy	72,621 +58,989	+433%	+$2.02M	0.3%	99
2016 Q1	$401K	Sell	13,632 -9,714	-42%	-$268K	0.06%	369
2015 Q4	$615K	Buy	23,346 +10,278	+79%	+$267K	0.17%	196
2015 Q3	$310K	Buy	+13,068	New	+$315K	0.1%	344
2015 Q2	–	Sell	-13,758	Closed	-$327K	–	461
2015 Q1	$327K	Buy	+13,758	New	+$309K	0.13%	287

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Secor Capital Advisors's EW Position: Q3 2016 in Review

Secor Capital Advisors sold out of Edwards Lifesciences (EW) in Q3 2016, closing a stake of 72,621 shares — an estimated $2.41M sold.

Secor Capital Advisors first reported a position in EW in Q1 2015 and held it in 5 quarters. The position peaked at $2.41M in Q2 2016. 695 funds tracked by Wall St. Rank hold EW as of Q3 2016.

Secor Capital Advisors reported no remaining Edwards Lifesciences position as of Q3 2016 after selling out during the quarter.
Secor Capital Advisors sold 72,621 Edwards Lifesciences shares in Q3 2016, an estimated $2.41M.
Secor Capital Advisors first reported a position in Edwards Lifesciences in Q1 2015 and held it in 5 quarters.
Secor Capital Advisors's Edwards Lifesciences position peaked at $2.41M in Q2 2016.
695 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Secor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.